NCT04883385View on ClinicalTrials.gov

Thromboprophylaxis by Low Molecular Heparin During the Post-partum Period

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

October 8, 2021

Primary Completion Date

July 9, 2022

Study Completion Date

July 9, 2022

Conditions
Thromboembolic Disease
Interventions
OTHER

medical data collection

collection of medical data from patients' medical records

Trial Locations (1)

91106

Centre Hospitalier Sud Francilien, Corbeil-Essonnes

All Listed Sponsors
lead

Centre Hospitalier Sud Francilien

OTHER

NCT04883385 - Thromboprophylaxis by Low Molecular Heparin During the Post-partum Period | Biotech Hunter | Biotech Hunter